Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase NA 3Phase 3 3Phase 4 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 1

Interventions

Carboplatin 6anlotinib 5lenvatinib 4Oxaliplatin 4Immune Checkpoint Inhibitors 4Cisplatin 4tislelizumab 3sintilimab 3Fluorouracil 3Capecitabine 3venetoclax 2Rosuvastatin Calcium 2Prednisone 2Megestrol Acetate 2Leucovorin 2Drug Therapy 2Dexmedetomidine 2Dexamethasone 2Cyclophosphamide 2Bevacizumab 2Aspirin 2zanubrutinib 1xiaojin wan 1trastuzumab deruxtecan 1trametinib 1tocilizumab 1testosterone 17 beta-cypionate 1tenofovir alafenamide 1telitacicept 1taxane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Not yet recruiting × pyrotinib × Clear all
NCT07600164 2026-05-20

Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer

Peking University People's Hospital

Phase 4 Not yet recruiting
500 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡